CD274 and gastric cancer: Evaluation of the therapeutic effects of anti-PD-1 mAbs against GC shows that patients with EBV (+) metastatic GC, as well as a high PD-L1 combined positive score (CPS) and tumors showing high microsatellite instability (MSI), have a favorable response7.